Sequana Medical krijgt Breakthrough Device status van de FDA voor haar alfapump® Een belegging in de aangeboden aandelen houdt substantiële risico's en onzekerheden in. Potentiële beleggers moeten het gehele Prospectus lezen dat zal worden voorbereid door de Vennootschap, en...

Sequana Medical receives Breakthrough Device designation from the FDA for its alfapump® An investment in the offered shares involves substantial risks and uncertainties. Prospective investors should read the entire Prospectus that will be prepared by the Company, and, in particular,...

Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients  at the International Gynecologic Cancer Society Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients  at the International Gynecologic Cancer Society                 Data also to be presented at the 68th...